Evaluation of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, HIB-conjugate combined vaccine (Pentaxim ™) at 2, 4, and 6 months of age plus hepatitis B vaccine at birth, 2, and 6 months of age in infants in Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 41, Issue 2, 2010, Pages 450-462

  Thisyakorn, Usa ^a   Chotpitayasunondh, Tawee ^b   Pancharoen, Chitsanu ^a   Chuenkitmongkol, Sunate ^c   Ortiz, Esteban ^d  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^b QUEEN SIRIKIT NATIONAL INSTITUTE OF CHILD HEALTH   (Thailand)

^c Sanofi Pasteur   (Thailand)

^d SANOFI PASTEUR   (France)

Author keywords

Acellular pertussis; Hepatitis B vaccine; Hib conjugate vaccine; Immunogenicity; Inactivated polio vaccine; Pentavalent combined vaccine; Safety; Thailand

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZA TYPE B POLYSACCHARIDE VACCINE-TETANUS TOXIN CONJUGATE; HAEMOPHILUS VACCINE; HEPATITIS B VACCINE; POLIOMYELITIS VACCINE; TETANUS TOXOID; VACCINE;

CLINICAL TRIAL; EPIDEMIOLOGY; EVALUATION STUDY; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; MULTICENTER STUDY; NEWBORN; THAILAND;

DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; MALE; POLIOVIRUS VACCINES; TETANUS TOXOID; THAILAND; VACCINES, CONJUGATE;

EID: 77956045306     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Anonymous. Pertussis vaccination: Use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP) - MMWR Recommend Rep 1997;46(RR-7):1-25.
2. Bonnet M-C, Dutta A. World wide experience with inactivated poliovirus vaccine. Vaccine 2008;26:4978-83.
3. Capeding RM, Cadorna-Carlos J, Book-Montellano M, Ortiz E. Immunogenicity and safety of a DTaP-IPV//PRP~T combination vaccine at 6, 10, 14 weeks of age (EPI schedule) and concomitant Hepatitis B vaccination at birth, 6, 14 or 6, 10, 14 weeks of age. WHO Bull 2008;86:443-51.
4. Carlsson RM, Claesson BA, Selstam U, et al. Safety and immunogenicity of a combined diphtheria, tetanus, acellular pertussisinactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age. Pediatr Infect Dis J 1998;17:1026-33.
5. Cherry J. Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials. Pediatr Infect Dis J 1997;16(suppl 4):S90-6.
6. th ed. 2006 Part 3. Recommended Immunization Public Health Agency of Canada. 2006. [Cited 2009 Jan 30]. Available from: URL: http://www.phac-aspc.gc.ca/publicat/ciggci/p03-01-eng. php
7. Decker MD. Principles of pediatric combination vaccines and practical issues related to use in clinical practice. Pediatr Infect Dis J 2001;20(11 suppl):S10-18.
8. Dodd D. Benefits of combination vaccines: effective vaccination on a simplified schedule. Am J Managed Care 2003;9(1 suppl)S6-12.
9. th ed. Philadelphia PA: Saunders, 2008;21:467-517.
10. Gustafsson L, Hessel L, Storsaeter J, Olin P. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics 2006;118:978-84.
11. Hessel L, Mast CH, Teyssou R. Effectiveness of the 2-component acellular pertussis combination vaccine 5 years experience of routine practice in Sweden [Abstract 18.023]. Int J Infect Dis 2004;8(suppl 1):S75.
12. nd ed. New York, NY: Marcel Dekker, 1997:387-416.
13. Institut Vielle Sanitaire (IVS). Vaccination schedule and recommendations from the "Haut conseil de la santé publique" in France. Bull èpidémiol Hebdomad 2009;16-17:145-75. [Cited 2009 Sept 21]. Available from : URL: http://www.invs.sante.fr/beh/2009/16-17/beh-16-17-2009.pdf
14. Kalies H, Grote V, Verstraeten T, Hessel L, Schmitt HJ, von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J 2006;25:507-12.
15. Kanra G, Selier T, Yurdakök K, et al. Immunogencity study of a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis vaccine used to reconstitute a freeze-dried Haemophilus influenzae type b vaccine (DTacP-IPV//PRP-T) administered simultaneously with a hepatitis B vaccine at two, three and four months of life. Vaccine 2000;18:947-54.
16. Lagos R, Kotloff, KL Hoffenbach A, et al. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four-and six month-old Chilean infants. Pediatr Infect Dis J 1998;17:294-304.
17. Lolekha S, Hiranchote A, Simasathien S. Safety and immunogenicity of combined or associated administration of PRP-T vaccine with diphtheria, tetanus and pertussis vaccine in Thai children. J Trop Pediatr 2001;47:24-9.
18. Mallet E, Fabre P, Pines E, et al. Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants. Pediatr Infect Dis J 2000;19:1119-27.
19. th European Societies for Paediatric Infectious Diseases, 1996.
20. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17:857-72.
21. Olin P, Hallander H. Marked decline in pertussis followed reintroduction of pertussis vaccination in Sweden. Euro Surveill 1999;4:128-9.
22. Olsen SJ, Dejsirilert S, Sangsuk L, Chunsutiwat S, Dowell SF. Frequent Haemophilus influenzae type B colonization in rural Thailand. Pediatr Infect Dis J 2005;24:739-42.
23. Rerks-Ngarm S, Treleaven SC, Chunsuttiwat S, et al. Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand. Vaccine 2004;25;22:975-83.
24. Swedish Institute for Infectious Disease Control (SIIDC). Pertussis surveillance in Sweden with enhanced follow-up of cohorts immunized with acellular pertussis vaccines. 2006; Appendix 2 SP-MSD. [Cited 2009 Jul. 28]. Available from: URL: http://www.smitt skyddsinstitutet.se/upload/PDF-filer/ seven-year-report-app-2-SP-MSD.pdf
25. Simondon F, Preziosi MP, Yam A, et al. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 1997;15:1606-12.
26. Sunakorn P. Current situation of Hemophilus infuenzae b diseases in Thailand. Comm Dis J 1996;22:301-7.
27. Vidor E, Plotkin SA. Immunogenicity of a twocomponent (PT & FHA) acellular pertussis vaccine in various combinations. Hum Vaccines 2008;4:328-40.
28. World Health Organization (WHO). Vaccine preventable diseases monitoring system: Country profiles. 1996. [Cited 2009 Jul. 15]. Available from: URL: http://www.who. int/vaccines/globalsummary/immunization/countryprofileselect.cfm
29. World Health Organization (WHO). United Nations prequalified vaccines (WHO list of vaccines for purchase by UN agencies as of September 2009). 2009 [Cited 2009 Jul. 29]. Available from: URL: http://www.who.int/immunization- standards/vaccine-quality/pq-suppliers/en/index.html
30. st Meeting of the European Regional Certification Commission for Poliomyelitis Eradication: Copenhagen, Denmark, 9-11 June 2008a. [Cited 2009 Jul. 22]. Available from: URL: http://www.who.int/immunization/sage/5-EURO-Polio-RCC-Report.pdf
31. WHO Global Polio Eradication Initiative - Strategic Plan 2009-2013 Framework for the new GPEI Strategic Plan 2009-2013. 2008b. [Cited 2009 Jul. 22]. Available from: URL: http://www.polioeradication.org/content/publications/ PolioStrategic Plan09-13-Framework.pdf
32. World Health Organization (WHO). Thailand 2007 EPI Fact Sheet. 2007. [Cited 2009 Jul. 26]. Available from: URL: http://www.searo.who.int/vaccine/ LinkFiles/EPI2007/Thailand07.pdf
33. World Health Organization. The WHO position paper on Haemophilus influenzae type b conjugate vaccines. Weekly Epidemiol Rec 2006a; 81:445-52.
34. World Health Organization (WHO). Inactivated poliovirus vaccine following oral poliovirus vaccine cessation. Weekly Epidemiol Rec 2006b; 81:137-44.
35. World Health Organization (WHO). Pertussis vaccines. WHO position paper. Weekly Epidemiol Rec 2005;80:31-9.
36. World Health Organization. Expanded programme on immunization. Global advisory group-part 1. Weekly Epidemiol Rec 1992;67:11-5.